Relapsing Multiple Sclerosis
BRIUMVI Receives Green Light from European Commission as Treatment for Relapsing Multiple Sclerosis
SG Tylor
The European Commission (EC) gave the green light for the use of TG Therapeutics‘ BRIUMVI (ublituximab-xiiy) to treat relapsing forms ...
